Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04912518Not ApplicableRecruiting
Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction
CardioprotectionPercutaneous Coronary InterventionST-segment Elevation Myocardial Infarction (STEMI)
PrincipalinvestigatorStart date: 2021-05-27

Research Network

Collaboration Network

15 collaborators·42 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Zheng Zhang

LanZhou University

Moderately Similar
1 trials

Shared therapeutic areas:

CardioprotectionPercutaneous Coronary InterventionST-segment Elevation Myocardial Infarction (STEMI)

Worked with same sponsors:

Harbin Medical UniversityYangtze River Pharmaceutical Group Co., Ltd.
Collaborated on 1 trial
Similarity Score34%

Jian An

Shanxi Cardiovascular Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

CardioprotectionPercutaneous Coronary InterventionST-segment Elevation Myocardial Infarction (STEMI)

Worked with same sponsors:

Harbin Medical UniversityYangtze River Pharmaceutical Group Co., Ltd.
Collaborated on 1 trial
Similarity Score34%

Bo Yu, M.D., FACC

The Second Affiliated Hospital of Harbin Medical University

Moderately Similar
1 trials

Shared therapeutic areas:

CardioprotectionPercutaneous Coronary InterventionST-segment Elevation Myocardial Infarction (STEMI)

Worked with same sponsors:

Harbin Medical UniversityYangtze River Pharmaceutical Group Co., Ltd.
Collaborated on 1 trial
Similarity Score34%

Chengzhi Lu

Tianjin First Central Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

CardioprotectionPercutaneous Coronary InterventionST-segment Elevation Myocardial Infarction (STEMI)

Worked with same sponsors:

Harbin Medical UniversityYangtze River Pharmaceutical Group Co., Ltd.
Collaborated on 1 trial
Similarity Score34%

Xianhe Lin

The First Affiliated Hospital of Anhui Medical University

Moderately Similar
1 trials

Shared therapeutic areas:

CardioprotectionPercutaneous Coronary InterventionST-segment Elevation Myocardial Infarction (STEMI)

Worked with same sponsors:

Harbin Medical UniversityYangtze River Pharmaceutical Group Co., Ltd.
Collaborated on 1 trial
Similarity Score34%

Xiling Shou

Shaanxi Provincial People's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

CardioprotectionPercutaneous Coronary InterventionST-segment Elevation Myocardial Infarction (STEMI)

Worked with same sponsors:

Harbin Medical UniversityYangtze River Pharmaceutical Group Co., Ltd.
Collaborated on 1 trial
Similarity Score34%

Kai Liu

Mudanjiang cardiovascular hospital

Moderately Similar
2 trials

Shared therapeutic areas:

CardioprotectionPercutaneous Coronary InterventionST-segment Elevation Myocardial Infarction (STEMI)

Worked with same sponsors:

Harbin Medical UniversityYangtze River Pharmaceutical Group Co., Ltd.
Collaborated on 1 trial
Similarity Score34%

Xi Su

Wuhan Asia Heart Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

CardioprotectionPercutaneous Coronary InterventionST-segment Elevation Myocardial Infarction (STEMI)

Worked with same sponsors:

Harbin Medical UniversityYangtze River Pharmaceutical Group Co., Ltd.
Collaborated on 1 trial
Similarity Score34%

Fausto Biancari, MD, PhD

Oulu University Hospital

Related
3 trials

Shared therapeutic areas:

Percutaneous Coronary Intervention
Similarity Score10%

catherine GEINDRE

Assistance Publique Hopitaux De Marseille

Related
13 trials

Shared therapeutic areas:

Percutaneous Coronary Intervention
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04912518Not ApplicablePrincipalInvestigator

Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction

CardioprotectionPercutaneous Coronary InterventionST-segment Elevation Myocardial Infarction (STEMI)
Recruiting

All 1 trials loaded